Heron Therapeutics (HRTX) Current Deferred Revenue (2010 - 2018)
Heron Therapeutics' (HRTX) quarterly Current Deferred Revenue came in at $14.0 million in Q4 2018, up 407.06% YoY from $2.8 million in Q4 2017, and up 33.12% on a QoQ basis from $10.5 million in Q3 2018.
Heron Therapeutics (HRTX) Current Deferred Revenue (2010 - 2018) Analysis & Trends
Heron Therapeutics (HRTX) has 4 years of Current Deferred Revenue data on file, last reported at $14.0 million in Q4 2018.
- Quarterly Current Deferred Revenue rose 407.06% year-over-year to $14.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $14.0 million (up 407.06% YoY) and the FY2018 annual result came in at $14.0 million, up 407.06% from the prior year.
- Current Deferred Revenue grew to $14.0 million in Q4 2018, from $10.5 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $14.0 million in Q4 2018 to a low of $1.1 million in Q4 2016.
- A 3-year average of $6.2 million and a median of $5.2 million in 2017 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 407.06% in 2018, down 55.21% in 2018.
- Tracing HRTX's Current Deferred Revenue over 3 years: stood at $1.1 million in 2016, then soared by 151.41% to $2.8 million in 2017, then surged by 407.06% to $14.0 million in 2018.
- The last three Current Deferred Revenue figures came in at $14.0 million (Q4 2018), $10.5 million (Q3 2018), and $9.4 million (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Heron Therapeutics | 59.96 Mn | 17.29 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 14.01 Mn |
| Sep 30, 2018 | 10.52 Mn |
| Jun 30, 2018 | 9.44 Mn |
| Mar 31, 2018 | 2.35 Mn |
| Dec 31, 2017 | 2.76 Mn |
| Sep 30, 2017 | 5.56 Mn |
| Jun 30, 2017 | 4.79 Mn |
| Mar 31, 2017 | 5.24 Mn |
| Dec 31, 2016 | 1.10 Mn |
| Dec 31, 2010 | 237,000.00 |